RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Atypical Ductal Hyperplasia: Risk Factors for Predicting Pathologic Upgrade on Excisional Biopsy

      한글로보기

      https://www.riss.kr/link?id=A108196440

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose To determine the incidence of atypical ductal hyperplasia (ADH) in needle biopsy and the upgrade rate to carcinoma, and to evaluate difference in findings between the upgrade and non-upgrade groups. Materials and Methods Among 9660 needle biop...

      Purpose To determine the incidence of atypical ductal hyperplasia (ADH) in needle biopsy and the upgrade rate to carcinoma, and to evaluate difference in findings between the upgrade and non-upgrade groups.
      Materials and Methods Among 9660 needle biopsies performed over 48 months, we reviewed the radiologic and histopathologic findings of ADH and compared the differences in imaging findings (mammography and breast US) and biopsy methods between the upgrade and non-upgrade groups.
      Results The incidence of ADH was 1.7% (169/9660). Of 112 resected cases and 30 cases followed- up for over 2 years, 35 were upgraded to carcinoma (24.6%, 35/142). The upgrade rates were significantly different according to biopsy methods: US-guided core needle biopsy (USCNB) (40.7%, 22/54) vs. stereotactic-vacuum-assisted biopsy (S-VAB) (16.0%, 12/75) vs. USguided VAB (US-VAB) (7.7%, 1/13) (p = 0.002). Multivariable analysis showed that only US-CNB (odds ratio = 5.19, 95% confidence interval: 2.16–13.95, p < 0.001) was an independent predictor for pathologic upgrade. There was no upgrade when a sonographic mass was biopsied by US-VAB (n = 7) Conclusion The incidence of ADH was relatively low (1.7%) and the upgrade rate was 24.6%.
      Surgical excision should be considered because of the considerable upgrade rate, except in the case of US-VAB.

      더보기

      참고문헌 (Reference)

      1 김지선 ; 한원식 ; Eun-Young Go ; 문형곤 ; Soo Kyung Ahn ; Hee-Chul Shin ; Jee-Man You ; Jung Min Chang ; 조나리야 ; 문우경 ; 박인애 ; Dong Young Noh, "Validation of a Scoring System for Predicting Malignancy in Patients Diagnosed with Atypical Ductal Hyperplasia Using an Ultrasound-Guided Core Needle Biopsy" 한국유방암학회 15 (15): 407-411, 2012

      2 Schiaffino S, "Vacuum assisted breast biopsy(VAB)excision of subcentimeter microcalcifications as an alternative to open biopsy for atypical ductal hyperplasia" 91 : 20180003-, 2018

      3 Schiaffino S, "Upgrade rate of percutaneously diagnosed pure atypical ductal hyperplasia : systematic review and meta-analysis of 6458 lesions" 294 : 76-86, 2020

      4 정인하 ; 김민정 ; 문희정 ; 윤정현 ; 김은경, "Ultrasonography-guided 14-gauge core biopsy of the breast: results of 7 years of experience" 대한초음파의학회 37 (37): 55-62, 2018

      5 Sharma N, "The B3 conundrum-the radiologists’ perspective" 90 : 20160595-, 2017

      6 Degnim AC, "Surgical management of high-risk breast lesions" 93 : 329-340, 2013

      7 Degnim AC, "Stratification of breast cancer risk in women with atypia : a Mayo cohort study" 25 : 2671-2677, 2007

      8 Rageth CJ, "Second International Consensus Conference on lesions of uncertain malignant potential in the breast(B3 lesions)" 174 : 279-296, 2019

      9 Ko E, "Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy" 112 : 189-195, 2008

      10 Chae BJ, "Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy" 7 : 77-, 2009

      1 김지선 ; 한원식 ; Eun-Young Go ; 문형곤 ; Soo Kyung Ahn ; Hee-Chul Shin ; Jee-Man You ; Jung Min Chang ; 조나리야 ; 문우경 ; 박인애 ; Dong Young Noh, "Validation of a Scoring System for Predicting Malignancy in Patients Diagnosed with Atypical Ductal Hyperplasia Using an Ultrasound-Guided Core Needle Biopsy" 한국유방암학회 15 (15): 407-411, 2012

      2 Schiaffino S, "Vacuum assisted breast biopsy(VAB)excision of subcentimeter microcalcifications as an alternative to open biopsy for atypical ductal hyperplasia" 91 : 20180003-, 2018

      3 Schiaffino S, "Upgrade rate of percutaneously diagnosed pure atypical ductal hyperplasia : systematic review and meta-analysis of 6458 lesions" 294 : 76-86, 2020

      4 정인하 ; 김민정 ; 문희정 ; 윤정현 ; 김은경, "Ultrasonography-guided 14-gauge core biopsy of the breast: results of 7 years of experience" 대한초음파의학회 37 (37): 55-62, 2018

      5 Sharma N, "The B3 conundrum-the radiologists’ perspective" 90 : 20160595-, 2017

      6 Degnim AC, "Surgical management of high-risk breast lesions" 93 : 329-340, 2013

      7 Degnim AC, "Stratification of breast cancer risk in women with atypia : a Mayo cohort study" 25 : 2671-2677, 2007

      8 Rageth CJ, "Second International Consensus Conference on lesions of uncertain malignant potential in the breast(B3 lesions)" 174 : 279-296, 2019

      9 Ko E, "Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy" 112 : 189-195, 2008

      10 Chae BJ, "Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy" 7 : 77-, 2009

      11 Yeh IT, "Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen" 127 : 49-54, 2003

      12 Peña A, "Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia" 164 : 295-304, 2017

      13 Krishnamurthy S, "Multidisciplinary considerations in the management of high-risk breast lesions" 198 : W132-W140, 2012

      14 Brem RF, "Management of breast atypical ductal hyperplasia : now and the future" 294 : 87-88, 2020

      15 Forgeard C, "Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients" 196 : 339-345, 2008

      16 Cao C, "Impact of pulmonary function on pulmonary complications after robotic-assisted thoracoscopic lobectomy" 57 : 338-342, 2019

      17 Acheson MB, "Histologic correlation of image-guided core biopsy with excisional biopsy of nonpalpable breast lesions" 132 : 815-818, 1997

      18 Forester ND, "High risk (B3) breast lesions: what is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis" 45 : 519-527, 2019

      19 Rageth CJ, "First International Consensus Conference on lesions of uncertain malignant potential in the breast(B3 lesions)" 159 : 203-213, 2016

      20 Deshaies I, "Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy" 20 : 50-55, 2011

      21 Wagoner MJ, "Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision" 131 : 112-121, 2009

      22 Ely KA, "Core biopsy of the breast with atypical ductal hyperplasia : a probabilistic approach to reporting" 25 : 1017-1021, 2001

      23 Ellis IO, "Best practice no 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment" 57 : 897-902, 2004

      24 Allison KH, "Atypical ductal hyperplasia on vacuum-assisted breast biopsy : suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade" 42 : 41-50, 2011

      25 Nguyen CV, "Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications : considerations for surgical excision" 18 : 752-761, 2011

      26 Renshaw AA, "Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies" 116 : 92-96, 2001

      27 Sneige N, "Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision" 119 : 248-253, 2003

      28 Liberman L, "Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions : an indication for surgical biopsy" 164 : 1111-1113, 1995

      29 Mesurolle B, "Atypical ductal hyperplasia diagnosed at sonographically guided core needle biopsy : frequency, final surgical outcome, and factors associated with underestimation" 202 : 1389-1394, 2014

      30 Rageth CJ, "Atypical ductal hyperplasia and the risk of underestimation : tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens" 26 : 452-458, 2019

      31 Lin PH, "Accuracy of stereotactic core-needle breast biopsy in atypical ductal hyperplasia" 175 : 380-382, 1998

      32 Sickles EA, "ACR BI-RADSⓇ atlas: breast imaging reporting and data system" American College of Radiology 5-175, 2013

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2024 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2021-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2020-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2017-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2016-11-24 학술지명변경 외국어명 : Journal of The Korean Radiological Society -> Journal of the Korean Society of Radiology (JKSR) KCI등재
      2016-11-15 학회명변경 영문명 : The Korean Radiological Society -> The Korean Society of Radiology KCI등재
      2013-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-09-15 학술지명변경 한글명 : 대한방사선의학회지 -> 대한영상의학회지 KCI등재
      2003-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2002-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2000-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.1 0.1 0.07
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.06 0.05 0.258 0.01
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼